Ascelia Pharma AB
STO:ACE

Watchlist Manager
Ascelia Pharma AB Logo
Ascelia Pharma AB
STO:ACE
Watchlist
Price: 3.015 SEK -0.99%
Market Cap: 382.5m SEK

Wall Street
Price Targets

ACE Price Targets Summary
Ascelia Pharma AB

Wall Street analysts forecast ACE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACE is 8.16 SEK with a low forecast of 6.565 SEK and a high forecast of 9.975 SEK.

Lowest
Price Target
6.565 SEK
118% Upside
Average
Price Target
8.16 SEK
171% Upside
Highest
Price Target
9.975 SEK
231% Upside
Ascelia Pharma AB Competitors:
Price Targets
TNG
Transgene SA
76% Upside
ABOS
Acumen Pharmaceuticals Inc
203% Upside
UTHR
United Therapeutics Corp
3% Upside
RNA
Avidity Biosciences Inc
3% Upside
ORY
Oryzon Genomics SA
149% Upside
ZEAL
Zealand Pharma A/S
64% Upside
BIOPOR
Bioporto A/S
281% Upside
OXB
Oxford BioMedica PLC
27% Upside

Revenue
Forecast

Revenue Estimate
Ascelia Pharma AB

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Ascelia Pharma AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat

Net Income
Forecast

Net Income Estimate
Ascelia Pharma AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-59%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACE's stock price target?
Price Target
8.16 SEK

According to Wall Street analysts, the average 1-year price target for ACE is 8.16 SEK with a low forecast of 6.565 SEK and a high forecast of 9.975 SEK.

Back to Top